Haleon Plc - ADR (HLN) | Stock Overview & Key Data
Haleon Plc - ADR Performance Comparison
Stock Range
Today's Range
Low: $9.60
High: $9.67
on August 15, 2025
52 Week Range
Low: $8.86
High: $11.42
on January 14, 2025
on June 2, 2025
All-Time High: $11.42 on June 2, 2025
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$43.6B
EPS
0.45
P/E Ratio (TTM)
21.58
Forward P/E
23.12
P/B Ratio
5.48
PEG Ratio
23.12
Div. Yield
1.63%
ROE
9.38%
Beta
0.240
Debt to Equity
53.41
Financial Highlights
Profitability
Gross Margin
55.38%
Operating Margin
22.21%
Profit Margin
13.81%
Returns and Earnings
Return on Assets (TTM)
4.61%
Return on Equity (TTM)
9.38%
EBITDA
$2.3B
Net Income (TTM)
$2.1B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$1.63
Quarterly Revenue Growth (YoY)
-1.30%
Quarterly Earnings Growth (YoY)
33.00%
Dividend Information
Last 12-Month Dividend
$0.17
Current Dividend Yield
1.63%
3-Year Average Dividend Yield
0.91%
3-Year Average Annual Dividend
$0.11
3-Year Total Dividends
$0.34
Ex-Dividend Date
April 25, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Haleon Plc - ADR HLN | 43.57B Large-cap | 1.15% | -0.82% | -9.56% | -3.40% | 2.22% | -0.31% | 61.37% | 30.23% |
| Zoetis ZTS | 65.30B Large-cap | 4.59% | 0.82% | -3.89% | -1.51% | -5.23% | -16.11% | -9.09% | -2.69% |
| Intra-Cellular ITCI | 14.05B Large-cap | 0.14% | 0.45% | 56.54% | 81.59% | 56.54% | 92.68% | 104.13% | 700.67% |
| United Therapeutics UTHR | 13.63B Large-cap | 3.86% | 6.78% | 3.03% | -16.01% | -13.07% | -2.45% | 39.52% | 191.96% |
| Neurocrine NBIX | 13.05B Large-cap | 6.31% | 1.26% | 10.50% | 16.61% | -3.60% | -8.35% | 24.21% | 17.50% |
| Viatris VTRS | 12.46B Large-cap | 9.38% | 18.81% | 20.71% | -2.30% | -14.57% | -9.01% | 0.38% | -33.65% |
Ownership & Short Interest
Insider Ownership
0.02%
Institutional Ownership
12.88%
Shares Short
17M
Short Ratio
1.39
Short % of Shares Outstanding
0.39%
Average 10-Day Volume
10M
Average 90-Day Volume
11M
Haleon Plc - ADR Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Haleon Plc - ADR would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is HLN's 52-week high and low?
- In the last 52 weeks, Haleon Plc - ADR reached a high of $11.42 (on June 2, 2025) and a low of $8.86 (on January 14, 2025).
- What is the market cap and P/E ratio for HLN?
- Curious about Haleon Plc - ADR's size and valuation? Its market capitalization stands at 43.57B. When it comes to valuation, the P/E ratio (trailing twelve months) is 21.58, and the forward P/E (looking ahead) is 23.12.
- Does HLN pay dividends? If so, what's the yield?
- Yes, Haleon Plc - ADR is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.63%, and the company has paid an average of $0.11 per share annually over the past 3 years.
- Who are Haleon Plc - ADR's main competitors or similar companies to consider before investing?
When looking at Haleon Plc - ADR, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Zoetis
ZTS65.30B Healthcare Drug Manufacturers - Specialty & Generic -16.11% -9.09% Intra-Cellular
ITCI14.05B Healthcare Drug Manufacturers - Specialty & Generic 92.68% 104.13% United Therapeutics
UTHR13.63B Healthcare Drug Manufacturers - Specialty & Generic -2.45% 39.52% Neurocrine
NBIX13.05B Healthcare Drug Manufacturers - Specialty & Generic -8.35% 24.21% Viatris
VTRS12.46B Healthcare Drug Manufacturers - Specialty & Generic -9.01% 0.38% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Haleon Plc - ADR? (e.g., ROE, Debt/Equity)
- To get a sense of Haleon Plc - ADR's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 9.38%, the Debt to Equity ratio from the most recent quarter is 53.41, and its Gross Profit Margin stands at 55.38%.
- What is the recent revenue and earnings growth for HLN?
- Looking at Haleon Plc - ADR's growth, its revenue over the trailing twelve months (TTM) was $15B. Compared to the same quarter last year (YoY), quarterly revenue grew by -1.30%, and quarterly earnings saw a YoY growth of 33.00%.
- How much of HLN stock is held by insiders and institutions?
- Wondering who owns Haleon Plc - ADR stock? Company insiders (like executives and directors) hold about 0.02% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 12.88%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.